Fits Your Workflow
GenASIs HiPath is a digital pathology solution that integrates with the lab’s existing microscope and hardware. After image capture of the region of interest, GenASIs HiPath automatically analyses and scores the sample based on the assay being used. Within seconds, pathologists obtain statistical analysis which is accurate, objective and repeatable.
GenASIs HiPath brings new capabilities to your microscope, and opens up a complete digital pathology solution at a fraction of the cost of whole slide imaging, while maintaining existing workflow and methodologies.
Accurate, Repeatable and Standardised Results
GenASIs HiPath helps to reduce subjectivity by scoring all detected cells. A higher cell count means the statistical value of the results is more accurate and represents a valuable quantitative analysis of the tissue.
GenASIs HiPath supports analysis of a variety of antibodies and bright field ISH samples (e.g. HER2, ER, PR, Ki-67, CISH).
FDA cleared for the following GenASIs applications: ALK, BandView, FISHView, UroVysion, CEP XY & HER2/neu FISH and IHC family for: HER2,ER,PR and ki67.
All other products and applications are intended for research use.
GenASIs HiPath for CISH
GenASIs HiPath is a computer aided evaluation for immunohistochemistry and CISH assays that assists pathologists in reaching accurate, repeatable and standardised analysis. An easy to use tool that integrates with any standard microscope, GenASIs HiPath offers labs all the benefits of digital pathology without having to make a large upfront investment in WSI.
HER2 CISH assay is an FDA-approved alternative to HER2 fluorescent in situ hybridisation (FISH). With a nearly 100% concordance rate with HER2 FISH, HER2 CISH allows pathologists to view tissue morphology and gene expression simultaneously by utilising a bright-field microscope.